Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial

P. Kenemans, N.J. Bundred, J.M. Foidart, E. Kubista, B. von Schoultz, P. Sismondi, R. Vassilopoulou-Sellin, C.H. Yip, J.C. Egberts, M. Mol-Arts, R. Mulder, S. van Os, M.W. Beckmann

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)135-146
JournalLancet Oncology
Volume10
Issue number2
DOIs
Publication statusPublished - 2009

Cite this

Kenemans, P. ; Bundred, N.J. ; Foidart, J.M. ; Kubista, E. ; von Schoultz, B. ; Sismondi, P. ; Vassilopoulou-Sellin, R. ; Yip, C.H. ; Egberts, J.C. ; Mol-Arts, M. ; Mulder, R. ; van Os, S. ; Beckmann, M.W. / Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. In: Lancet Oncology. 2009 ; Vol. 10, No. 2. pp. 135-146.
@article{d3124a60225e4e8d86472d6620474294,
title = "Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial",
author = "P. Kenemans and N.J. Bundred and J.M. Foidart and E. Kubista and {von Schoultz}, B. and P. Sismondi and R. Vassilopoulou-Sellin and C.H. Yip and J.C. Egberts and M. Mol-Arts and R. Mulder and {van Os}, S. and M.W. Beckmann",
year = "2009",
doi = "10.1016/S1470-2045(08)70341-3",
language = "Undefined/Unknown",
volume = "10",
pages = "135--146",
journal = "Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "2",

}

Kenemans, P, Bundred, NJ, Foidart, JM, Kubista, E, von Schoultz, B, Sismondi, P, Vassilopoulou-Sellin, R, Yip, CH, Egberts, JC, Mol-Arts, M, Mulder, R, van Os, S & Beckmann, MW 2009, 'Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial' Lancet Oncology, vol. 10, no. 2, pp. 135-146. https://doi.org/10.1016/S1470-2045(08)70341-3

Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. / Kenemans, P.; Bundred, N.J.; Foidart, J.M.; Kubista, E.; von Schoultz, B.; Sismondi, P.; Vassilopoulou-Sellin, R.; Yip, C.H.; Egberts, J.C.; Mol-Arts, M.; Mulder, R.; van Os, S.; Beckmann, M.W.

In: Lancet Oncology, Vol. 10, No. 2, 2009, p. 135-146.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial

AU - Kenemans, P.

AU - Bundred, N.J.

AU - Foidart, J.M.

AU - Kubista, E.

AU - von Schoultz, B.

AU - Sismondi, P.

AU - Vassilopoulou-Sellin, R.

AU - Yip, C.H.

AU - Egberts, J.C.

AU - Mol-Arts, M.

AU - Mulder, R.

AU - van Os, S.

AU - Beckmann, M.W.

PY - 2009

Y1 - 2009

U2 - 10.1016/S1470-2045(08)70341-3

DO - 10.1016/S1470-2045(08)70341-3

M3 - Article

VL - 10

SP - 135

EP - 146

JO - Lancet Oncology

JF - Lancet Oncology

SN - 1470-2045

IS - 2

ER -